Cargando…

Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy

Inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC) are multifactorial diseases with still unknown aetiology and an increasing prevalence and incidence worldwide. Despite plentiful therapeutic options for IBDs, the lack or loss of response in certain patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiendl, Maximilian, Becker, Emily, Müller, Tanja M., Voskens, Caroline J., Neurath, Markus F., Zundler, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129496/ https://www.ncbi.nlm.nih.gov/pubmed/34017333 http://dx.doi.org/10.3389/fimmu.2021.656452

Ejemplares similares

Intestinal Mucosal Wound Healing and Barrier Integrity in IBD–Crosstalk and Trafficking of Cellular Players
por: Sommer, Katrin, et al.
Publicado: (2021)

Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19
por: Müller, Tanja M., et al.
Publicado: (2021)

Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets
por: Dedden, Mark, et al.
Publicado: (2023)

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
por: Mühl, Laura, et al.
Publicado: (2021)

Nr4a1-dependent non-classical monocytes are important for macrophage-mediated wound healing in the large intestine
por: Heidbreder, Karin, et al.
Publicado: (2023)

Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
por: Becker, Emily, et al.
Publicado: (2022)

Total Recall: Intestinal T(RM) Cells in Health and Disease
por: Paap, Eva-Maria, et al.
Publicado: (2021)

Novel Small Molecules in IBD: Current State and Future Perspectives
por: Jefremow, André, et al.
Publicado: (2023)

Editorial: Targeting Leukocyte Trafficking: Insights and Future Directions
por: Sumagin, Ronen, et al.
Publicado: (2021)

Anti‐β7 integrin treatment impedes the recruitment on non‐classical monocytes to the gut and delays macrophage‐mediated intestinal wound healing
por: Sommer, Katrin, et al.
Publicado: (2023)

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma
por: Zundler, Sebastian, et al.
Publicado: (2023)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

Immunology of IL-12: An update on functional activities and implications for disease
por: Ullrich, Karen A.-M., et al.
Publicado: (2020)

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects
por: Zundler, Sebastian, et al.
Publicado: (2017)

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles
por: Fuchs, Friederike, et al.
Publicado: (2017)

Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer
por: Zundler, Sebastian, et al.
Publicado: (2016)

Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
por: Fischer, Anika, et al.
Publicado: (2016)

Dysregulated inflammasome activity in intestinal inflammation – Insights from patients with very early onset IBD
por: Illig, David, et al.
Publicado: (2022)

Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis
por: Müller, Tanja M., et al.
Publicado: (2023)

Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
por: Wiesinger, Manuel, et al.
Publicado: (2017)

Oligonucleotides—A Novel Promising Therapeutic Option for IBD
por: Scarozza, Patrizio, et al.
Publicado: (2019)

Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis
por: Saiz-Gonzalo, Gonzalo, et al.
Publicado: (2021)

IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
por: Atreya, Raja, et al.
Publicado: (2022)

Imaging of Mucosal Inflammation: Current Technological Developments, Clinical Implications, and Future Perspectives
por: Waldner, Maximilian J., et al.
Publicado: (2017)

Microbiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBD
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2015)

Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial
por: Voskens, Caroline J, et al.
Publicado: (2021)

Su095 REAL-TIME DEFORMABILITY CYTOMETRY (RT-DC) REVEALS NOVEL CORRELATIONS BETWEEN INFLAMMATION AND MECHANICAL PROPERTIES OF NEUTROPHILS IN IBD PATIENTS
por: Ganzleben, Ingo, et al.
Publicado: (2021)

All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
por: Jefremow, André, et al.
Publicado: (2020)

Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD
por: Klepsch, Victoria, et al.
Publicado: (2019)

The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD
por: Astorga, Jessica, et al.
Publicado: (2022)

Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype
por: Gonzalez Acera, Miguel, et al.
Publicado: (2021)

α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis
por: Melde, Michaela, et al.
Publicado: (2021)

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
por: Atreya, Raja, et al.
Publicado: (2020)

Application of Comparative Transcriptional Genomics to Identify Molecular Targets for Pediatric IBD
por: Fang, Kai, et al.
Publicado: (2015)

ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure
por: Schulz-Kuhnt, Anja, et al.
Publicado: (2020)

In silico analysis of alternative splicing events implicated in intracellular trafficking during B-lymphocyte differentiation
por: Ostwaldt, Felix, et al.
Publicado: (2022)

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
por: Besendorf, Laura, et al.
Publicado: (2022)

RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
por: Sultan, Mutaz, et al.
Publicado: (2022)

The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics
por: Lelong, Margaux, et al.
Publicado: (2023)

The Effects of Trained Innate Immunity on T Cell Responses; Clinical Implications and Knowledge Gaps for Future Research
por: Murphy, Dearbhla M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8ndq7bklanfgt4suvonv3dmfa